2-naphthylamine has been researched along with Idiopathic Parkinson Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fink, AL; Li, J; Zhu, M | 1 |
Dijkstra, D; Johnson, SJ; Meltzer, LT; Pugsley, TA; Rodenhuis, N; Sundell, S; Venhuis, BJ; Wikström, HV; Wise, LD; Wustrow, D | 1 |
2 other study(ies) available for 2-naphthylamine and Idiopathic Parkinson Disease
Article | Year |
---|---|
The association of alpha-synuclein with membranes affects bilayer structure, stability, and fibril formation.
Topics: 2-Naphthylamine; alpha-Synuclein; Fluorescent Dyes; Humans; In Vitro Techniques; Kinetics; Laurates; Lipid Bilayers; Microscopy, Atomic Force; Molecular Structure; Nerve Tissue Proteins; Parkinson Disease; Protein Binding; Protein Conformation; Protein Structure, Secondary; Recombinant Proteins; Spectrometry, Fluorescence; Synucleins | 2003 |
A new type of prodrug of catecholamines: an opportunity to improve the treatment of Parkinson's disease.
Topics: 2-Naphthylamine; Administration, Oral; Animals; Antiparkinson Agents; Catecholamines; Crystallography, X-Ray; Male; Microdialysis; Molecular Conformation; Parkinson Disease; Prodrugs; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereoisomerism; Structure-Activity Relationship; Tetrahydronaphthalenes | 2002 |